Solvay unit bid war looms after Abbott offer: source
1 of 1
Belgium's Christian Jourquin, chief executive officer of Belgian drug and chemicals maker Solvay, presents the annual results of the company in Brussels February 19, 2009. Belgian drugs, chemicals and plastics maker Solvay missed forecasts with a 53 percent fall in fourth-quarter operating profit and said market conditions remained difficult, knocking its shares on Thursday. (Reuters Photo / Thierry Roge )